Send your comments and tips to firstname.lastname@example.org
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Wednesday, April 4, 2007
Computers don't increase mammogram accuracy and may hurt, study says
Computer-aided detection systems not only failed to detect more breast cancer in women who had screening mammograms, researchers report in tomorrow's New England Journal of Medicine, but it also may have harmed them by generating a higher number of false-positive readings, resulting in significantly more call-backs for repeat mammograms and biopsies.
Dr. Joshua J. Fenton of the University of California, Davis, and his co-authors studied CAD in 429,345 mammograms, the largest trial to date since it was approved by the Food and Drug Administration in 1998. They found that about 157 women would be called back for another mammogram and 15 women would undergo biopsies in order to detect one additional case of cancer, possibly a ductal carcinoma in situ, which is noninvasive and highly treatable.
Fenton's results "constitute a substantial hit to this technology," Dr. Ferris M. Hall of Beth Israel Deaconess Medical Center writes in an editorial in the same issue. Early studies had said CAD helped detect 10 to 15 percent more cases of breast cancers.
CAD programs analyze digitized mammograms and mark suspicious areas for review by radiologists.
CAD picks up a disproportionate number of clustered microcalcifications, which are the sign of ductal carcinoma in situ. DCIS makes up 25 percent of breast cancers diagnosed in the United States, Hall writes, but DCIS may never progress to cancer in a woman's lifetime.
"CAD does find a few more cancers in DCIS, so it's got some usefulness, but in all likelihood it's not going to save many lives," he said in an interview.
A study of CAD and mortality will take more time, Hall said, as it did for screening mammography.
"Mortality is the gold standard," he said. "Finding extra cancers does not prove that you have affected anything. You may have found a cancer that you would find next year anyway."
MRI screenings do a better job, Hall said, but cost and the need for interpretive expertise are delaying its adoption, as they did for mammography before it was accepted, he said.